文献速递主动脉外科心外重症与机械循环支持

急性A型主动脉夹层术后急性肾损伤早期与标准肾替代治疗随机试验

Randomized Trial of Early vs Standard Renal Replacement Therapy in Patients With Acute Kidney Injury After Type A Aortic Dissection.
PubMed 文献 · Ann Thorac Surg · 2025-01-04

该单中心随机对照试验纳入212例急性A型主动脉夹层术后KDIGO 2期且血浆NGAL>150 ng/mL的急性肾损伤患者,比较早期(诊断2期后6小时内)与标准(3期后8小时内)启动肾替代治疗。

要点

  • 器官功能障碍及ICU/住院时间无显著差异

核心结论

  • 早期启动肾替代治疗可改善急性A型主动脉夹层术后严重急性肾损伤患者的预后。

研究设计与样本

  • 单中心随机对照试验,纳入212例急性A型主动脉夹层术后KDIGO 2期且血浆NGAL>150 ng/mL的急性肾损伤患者,等比例随机分为早期RRT组(n=106)和标准治疗组(n=106)。

主要发现

  • 两组器官功能障碍及ICU和住院时间无显著差异。

关键数值与推荐

  • 早期RRT组在诊断KDIGO 2期后6小时内启动RRT。
  • 标准治疗组在KDIGO 3期后8小时内启动RRT。
  • 纳入标准包括术后严重急性肾损伤KDIGO 2期且血浆NGAL>150 ng/mL,且无直接与肾衰竭相关的潜在危及生命的并发症。

临床怎么用

  • 对于急性A型主动脉夹层术后KDIGO 2期且NGAL>150 ng/mL的急性肾损伤患者,可考虑在6小时内早期启动RRT以降低死亡率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We sought to study whether early initiation of renal replacement therapy (RRT) could reduce 90-day mortality and improve clinical outcomes in patients with acute kidney injury after acute type A aortic dissection. METHODS: This single-center, randomized, controlled trial enrolled acute type A aortic dissection patients with severe postoperative acute kidney injury classified as Kidney Disease: Improving Global Outcomes (KDIGO) stage 2 and with a plasma neutrophil gelatinase-associated lipocalin level >150 ng/mL who did not have potentially life-threatening complications directly related to renal failure. Patients were randomized equally into 2 groups: the early RRT group received RRT within 6 hours of diagnosis of KDIGO stage 2; the standard treatment group was managed with RRT initiated within 8 hours of stage 3. The primary outcome was mortality at 90 days. Secondary outcomes included in-hospital mortality, 30-day mortality, clinical evidence of organ dysfunction, duration of RRT, and intensive care unit and hospital lengths of stay. RESULTS: Among 212 patients, all patients in the early group (n =106) and 100 of 106 patients in the standard treatment group received RRT. Early initiation of RRT significantly reduced 90-day mortality (30.2%) compared with standard initiation (51.9%; P = .001). In-hospital mortality was lower in the early group (24.5% vs 38.7%; P = .03), and 30-day mortality was also reduced (28.3% vs 43.4%; P = .02). Nevertheless, there was no significant difference in organ dysfunction or in intensive care unit and hospital lengths of stay. CONCLUSIONS: Our results revealed that early initiation of RRT improves patient prognosis.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Jiao R, Lu X, Liu M, et al. Randomized Trial of Early vs Standard Renal Replacement Therapy in Patients With Acute Kidney Injury After Type A Aortic Dissection. Ann Thorac Surg. 2025. PMID: 39761941. doi:10.1016/j.athoracsur.2024.10.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。